Globus Medical ROA 2010-2022 | GMED

Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Globus Medical ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2022-09-30 $0.16B $1.98B 7.90%
2022-06-30 $0.16B $1.92B 7.97%
2022-03-31 $0.14B $2.00B 7.38%
2021-12-31 $0.15B $1.96B 8.02%
2021-09-30 $0.19B $1.91B 10.45%
2021-06-30 $0.18B $1.83B 10.84%
2021-03-31 $0.12B $1.74B 7.53%
2020-12-31 $0.10B $1.68B 6.62%
2020-09-30 $0.10B $1.54B 6.31%
2020-06-30 $0.09B $1.47B 6.00%
2020-03-31 $0.15B $1.48B 10.11%
2019-12-31 $0.16B $1.53B 10.86%
2019-09-30 $0.15B $1.45B 10.66%
2019-06-30 $0.14B $1.39B 10.86%
2019-03-31 $0.15B $1.34B 11.83%
2018-12-31 $0.16B $1.30B 12.92%
2018-09-30 $0.14B $1.24B 12.41%
2018-06-30 $0.14B $1.19B 12.17%
2018-03-31 $0.12B $1.13B 11.23%
2017-12-31 $0.11B $1.08B 10.61%
2017-09-30 $0.11B $1.04B 11.02%
2017-06-30 $0.11B $1.00B 11.41%
2017-03-31 $0.11B $0.96B 11.48%
2016-12-31 $0.10B $0.93B 11.75%
2016-09-30 $0.12B $0.90B 13.70%
2016-06-30 $0.12B $0.87B 14.11%
2016-03-31 $0.12B $0.84B 14.32%
2015-12-31 $0.11B $0.83B 14.38%
2015-09-30 $0.10B $0.80B 13.67%
2015-06-30 $0.10B $0.77B 13.99%
2015-03-31 $0.10B $0.74B 14.31%
2014-12-31 $0.09B $0.70B 14.49%
2014-09-30 $0.09B $0.65B 14.16%
2014-06-30 $0.08B $0.62B 14.38%
2014-03-31 $0.07B $0.60B 12.61%
2013-12-31 $0.07B $0.57B 13.18%
2013-09-30 $0.07B $0.53B 13.99%
2013-06-30 $0.06B $0.50B 13.95%
2013-03-31 $0.08B $0.47B 17.84%
2012-12-31 $0.07B $0.45B 18.68%
2012-09-30 $0.07B $0.42B 18.27%
2012-06-30 $0.07B $0.37B 25.88%
2012-03-31 $0.06B $0.36B 36.26%
2011-12-31 $0.06B $0.33B 68.09%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.483B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00